000 | 01970 a2200541 4500 | ||
---|---|---|---|
005 | 20250514015726.0 | ||
264 | 0 | _c20020506 | |
008 | 200205s 0 0 eng d | ||
022 | _a0167-594X | ||
024 | 7 |
_a10.1023/a:1012249216117 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTysnes, B B | |
245 | 0 | 0 |
_aBiological mechanisms of glioma invasion and potential therapeutic targets. _h[electronic resource] |
260 |
_bJournal of neuro-oncology _cJun 2001 |
||
300 |
_a129-47 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aAstrocytoma _xgenetics |
650 | 0 | 4 |
_aBrain Neoplasms _xgenetics |
650 | 0 | 4 |
_aCell Adhesion Molecules _xphysiology |
650 | 0 | 4 | _aCell Movement |
650 | 0 | 4 | _aChromosome Deletion |
650 | 0 | 4 |
_aChromosomes, Human, Pair 10 _xgenetics |
650 | 0 | 4 |
_aCytoskeleton _xdrug effects |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aEndopeptidases _xphysiology |
650 | 0 | 4 |
_aExtracellular Matrix _xmetabolism |
650 | 0 | 4 | _aForecasting |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aGenetic Therapy |
650 | 0 | 4 |
_aGlioblastoma _xgenetics |
650 | 0 | 4 |
_aGlioma _xgenetics |
650 | 0 | 4 |
_aGrowth Substances _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntegrins _xphysiology |
650 | 0 | 4 |
_aNeoplasm Invasiveness _xphysiopathology |
650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aNeoplasms, Experimental _xpathology |
650 | 0 | 4 | _aPTEN Phosphohydrolase |
650 | 0 | 4 |
_aPhosphoric Monoester Hydrolases _xgenetics |
650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
650 | 0 | 4 |
_aThromboxane-A Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
700 | 1 | _aMahesparan, R | |
773 | 0 |
_tJournal of neuro-oncology _gvol. 53 _gno. 2 _gp. 129-47 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1012249216117 _zAvailable from publisher's website |
999 |
_c11630623 _d11630623 |